(Q54160045)

25 May 2018

reason for preferred rank

title

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl‐2 oncoprotein (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

30 May 2024

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

author name string

O. Sangfelt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

A. Osterborg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

D. Grandér

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

E. Anderbring

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

A. Ost

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

H. Mellstedt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

S. Einhorn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591202

30 May 2024

language of work or name

English

0 references

publication date

1 October 1995

1 reference

25 May 2018

9 October 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7591202

full work available at URL

30 May 2024

number of pages

3

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910630207

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910630207

30 May 2024

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

International Journal of Cancer

30 May 2024

published in

1 reference

25 May 2018

volume

63

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

190-192

1 reference

25 May 2018

High doses of natural α-interferon (α-IFN) in the treatment of multiple myeloma - A pilot study from the Myeloma Group of Central Sweden (MGCS)

cites work

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

The role of the bcl-2 gene in lymphoma

30 May 2024

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Interferon exerts a cytotoxic effect on primary human myeloma cells

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Oral dosage of melphalan and response to treatment in multiple myeloma

30 May 2024

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

30 May 2024

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma

30 May 2024

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Intermittent melphalan and prednisolone therapy in plasma cell myeloma

30 May 2024

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Treatment of multiple myeloma with interferon alpha: the Scandinavian experience

30 May 2024

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Ras oncogene mutation in multiple myeloma

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Interferons in the treatment of multiple myeloma

30 May 2024

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

bcl-2 protein in non-small-cell lung carcinoma

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910630207

30 May 2024

Identifiers

1 reference

25 May 2018

1 reference

25 May 2018